第二十八天的安全性和有效性泰诺福韦Alafenamide（TAF）中富马

StephenW

Twenty-Eight Day Safety and Efficacy of Tenofovir Alafenamide (TAF) Fumarate in Chronic Hepatitis B (CHB) Patients
	Reported by Jules Levin AASLD Nov 1-5 2013 Wash DC Kosh Agarwal,1 Scott K. Fung,2 Tuan T. Nguyen,3 Wendy Cheng,4 Eric Sicard,5 Stephen D. Ryder,6 John F. Flaherty,7 Eileen Lawson,7Sally Zhao,7 Mani Subramanian,7 John G. McHutchison,7 Edward J. Gane,8 Graham R. Foster9 1Institute of Liver Studies, Kings College Hospital, London, United Kingdom; 2Toronto General Hospital, Toronto, Ontario, Canada; 3T. Nguyen Research and Education, San Diego, CA; 4Royal Perth Hospital, Perth, Western Australia, Australia; 5Algorithme Pharma, Montreal, Quebec, Canada; 6Nottingham University Hospitals NHS Trust and Biomedical Research Unit, Nottingham, United Kingdom; 7Gilead Sciences, Inc., Foster City, CA; 8Auckland Clinical Studies, Auckland, New Zealand; 9Queen Mary's University of London, Barts Health, United Kingdom

StephenW

Tenofovir alafanamide (TAF GS-7340) fumarate is a next generation prodrug of Tenofovir (TFV) that is more stable in plasma/tissues than Tenofovir disoproxil fumarate (TDF, Viread):
1. Provides high levels of active drug (TFV-diphosphate) in target cells (e.g. hepatocytes and lymphoid cells) at lower doese than TDF
2. Reduced systemic exposures of TFV offer the potential for an improved safety profile (e.g. bone/renal adverse events)

泰诺福韦alafanamide（TAF GS-7340）是下一代富马酸替诺福韦（TFV）的前药更稳定的血浆/组织比富马酸泰诺福韦（TDF，Viread的）：
1。提供高水平的活性药物（TFV-二磷酸）在靶细胞（如肝细胞和淋巴细胞）比TDF doese较低
2。 TFV降低系统性风险提供了潜在的提高了安全性
（如骨/肾功能不良事件）

齐欢畅2

StephenW

Efficient Hepatic Delivery of Tenofovir by Prodrug Tenofovir Alafenamide inNonclinical Studies Supports Low-Dose Treatment of Hepatitis B Virus                           Reported by Jules Levin HepDart 2013: December 8-12, 2013, Big Island, Hawaii E Murakami, D Babusis, T Wang, Y Park, E-I Lepist, J Hao and AS RayGilead Sciences, Inc., Foster City, CA, USA

                                                                       

ding1661

怎么没中文啊？

StephenW

回复 ding1661 的帖子

因为只有图像，没有文字.

简单地说, 替诺福韦
前体药物替诺福韦Alafenamide在非临床研究支持
低剂量治疗乙肝病毒.